Cart
sales@molnova.com
ARRY-403
CAS No. 1138669-65-4
ARRY-403( —— )
Catalog No. M34507 CAS No. 1138669-65-4
ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 785 | In Stock |
|
| 10MG | 1064 | In Stock |
|
| 25MG | 1568 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameARRY-403
-
NoteResearch use only, not for human use.
-
Brief DescriptionARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
-
DescriptionARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetGlucokinase
-
RecptorGlucokinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1138669-65-4
-
Formula Weight454.52
-
Molecular FormulaC20H18N6O3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1ncccc1Oc1cc(Sc2ccccn2)cnc1Nc1nc(ns1)[C@H](O)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MK-0941 mesylate
MK-0941 mesylate (MK0941) is a novel potent, orally active Glucokinase (GK) activator with EC50 of 0.240 and 0.065 uM in 2.5 and 10 mM glucose, respectively.
-
Oxfendazole
Oxfendazole is a broad spectrum benzimidazole anthelmintic.
-
TTP399
TTP399 (TTP-399) is a hepatoselective, oral Glucokinase (GK) activator with EC50 of 304 nM and 762 nM for human GK at high glucose concentration (15 mM) and normoglycemia (5 mM), respectively.
